Thermo Fisher Scientific sign license deal for novel biomarker assays Thermo Fisher Scientific.

Alere, Thermo Fisher Scientific sign license deal for novel biomarker assays Thermo Fisher Scientific , the world leader in serving science, announced it offers signed a long-term license agreement with Alere Inc today. To integrate its novel Thermo Scientific B.R.A.H.M.S. Alere, formerly Inverness Medical Innovations, is a worldwide leader in quick point-of-care diagnostics. Increased option of biomarker-based testing on the Triage platform will result in improved patient treatment in hospitals and principal care services. Casper, president and ceo of Thermo Fisher Scientific.To find out more ways pharmacists can improve medication adherence, click here. Continue Reading >> 4. Non-steroidal anti-inflammatory drug make use of in elderly patients Prescribing and dispensing medications appropriately can be challenging in complex patient populations. There are many things to consider before accurately assessing a patient&rsquo often;s health needs, including cognitive issues, lack of social support, and fixed budgets. NSAIDs pose a specific danger to elderly patients because the drugs are known to connect to antihypertensive therapies, in fact it is estimated that a lot more than 50 percent folks patients ages 65 or old have hypertension.